Mounjaro KwikPen changes in 2026 explained. Find out what is different about the updated pen, whether the injection process has changed, what happens to leftover medicine and why there is no fifth dose.
If you use Mounjaro® (tirzepatide) for weight management, you may notice that your KwikPen looks slightly different in 2026.
This is because an updated version of the Mounjaro KwikPen has been introduced. The change relates to the design of the pen mechanism rather than the medicine itself.
For patients, the most important point is simple: the way you use Mounjaro has not fundamentally changed.
The updated KwikPen still provides four weekly doses and needs to be primed before each injection. However, the internal mechanism has been modified to make it clearer when the pen has reached the end of its four doses.
This guide explains the Mounjaro KwikPen change, what you may notice and what you should do if you are unsure about your pen.
What is changing with the Mounjaro KwikPen in 2026?
Eli Lilly has introduced a modified version of the Mounjaro KwikPen.
The updated pen may look slightly different from the version you have previously used. However, the two versions work in the same way.
The main change is to the internal mechanism and plunger.
The updated design allows the plunger to travel further through the cartridge as the four doses are administered. This is intended to make it easier to recognise that the pen has reached the end of its usable doses.
So, while the appearance and internal mechanism may differ, the medicine and prescribed dose remain the same.
If you are currently prescribed Mounjaro, you do not need to change your treatment simply because you receive the updated version of the KwikPen.
Why has the Mounjaro pen changed?
One reason for the change is confusion about the amount of liquid that can appear to remain inside a KwikPen after the four weekly doses have been administered.
The Mounjaro KwikPen contains four fixed doses. It also contains additional volume that allows the pen to be primed before injections.
After the fourth dose, some liquid may still appear to be visible inside the cartridge.
This has led some patients to believe that they have another complete dose available.
However, the visible leftover liquid should not be treated as a fifth dose.
The updated pen design helps make the end of the pen more obvious by changing how far the internal plunger travels.
Does the new Mounjaro pen contain different medicine?
No.
The change is to the pen device, not the medicine itself.
Mounjaro contains tirzepatide, a prescription medicine used for weight management in eligible patients.
If you are considering treatment, you can learn more about Mounjaro weight loss treatment at SynovaMed.
The updated KwikPen does not mean that your prescribed Mounjaro dose has changed.
Does the Mounjaro injection process change?
No.
The updated KwikPen is used in the same general way as the previous version.
You should continue to follow the Instructions for Use supplied with your medication and the advice provided by your prescriber.
Mounjaro is administered once a week.
The KwikPen should be primed before each injection, and a new compatible needle should be used for each dose.
The manufacturer's UK guidance states that the pen contains four fixed doses and that users should follow the supplied instructions for preparing, priming, injecting and disposing of the pen.
If you are unsure how to use your pen, speak to your pharmacist or prescribing clinician before administering your next dose.
How many doses are in a Mounjaro KwikPen?
A Mounjaro KwikPen is designed to deliver four weekly doses.
This is important because some people may see medicine remaining inside the pen after their fourth injection and assume that another dose is available.
The remaining liquid does not mean that a complete fifth dose is available.
The manufacturer's guidance explains that the pen contains 2.4 mL, corresponding to four 0.6 mL doses, with additional volume to allow for priming.
Once you have administered the four intended doses, the pen should be discarded according to the instructions provided with your medication.
For more information about Mounjaro, including the available strengths and treatment process, visit the Mounjaro KwikPen treatment page.
Is there a fifth or "golden" dose in a Mounjaro KwikPen?
You may have seen people online referring to a "fifth dose", "golden dose" or leftover Mounjaro from the KwikPen.
This can be confusing.
The KwikPen is designed to deliver four doses, not five.
Although some liquid may remain visible after the fourth injection, this does not mean you should attempt to extract and inject the remaining medicine.
Trying to obtain additional medicine from the pen could result in an incomplete or inaccurate dose and may damage the device.
The manufacturer's guidance explains that medicine can remain in the pen after the four doses have been delivered and that an additional complete dose cannot be dialled.
For this reason, do not attempt to use leftover liquid as an additional weekly dose.
Why does liquid remain in the Mounjaro pen?
The presence of some liquid after the fourth injection can be normal.
A small amount of additional volume is included in the KwikPen to allow it to be primed before injections.
Priming is an important part of using the device because it helps remove air from the needle and confirms that the pen is functioning correctly.
The updated design aims to reduce confusion by making the plunger position after the final dose easier to recognise.
The important thing to remember is that the amount of visible liquid is not a reliable way to calculate how many doses remain.
The markings on the pen should not be used as dose indicators.
What does the new Mounjaro pen look like?
You may notice a difference in the position or appearance of the internal plunger.
The updated design allows the plunger to move further through the cartridge during treatment.
This means that after the fourth dose, the plunger should sit closer to the end of the cartridge than it may have done with the previous version.
You may therefore receive a pen that looks slightly different from one you used previously.
This does not necessarily mean that the pen is faulty or that you have received the wrong medication.
Always check the name, strength, expiry date and appearance of the medicine before use and follow the Instructions for Use supplied with your particular pen.
Can I still use my existing Mounjaro KwikPen?
If you have an existing KwikPen that has been supplied correctly and is within its use-by period, follow the instructions supplied with that pen.
The introduction of the modified device does not mean that patients need to change their treatment simply because the newer version looks different.
During a transition period, both versions may be encountered.
If you have any concerns about whether your pen is genuine, damaged, expired or appropriate for use, contact your dispensing pharmacy or prescribing clinician before using it.
Has the Mounjaro dose changed?
No.
The pen design change does not mean your prescribed dose has changed.
Mounjaro is available in different strengths, and your prescriber determines which strength is appropriate for you.
Dose increases should take place according to your individual treatment plan and clinical advice.
Do not increase your Mounjaro dose because you believe there is additional medicine left in the pen.
Likewise, do not take an extra injection to use up leftover liquid.
If you are unsure about your current Mounjaro dose, speak to your prescriber.
Do I still need to prime the Mounjaro KwikPen?
Yes.
The manufacturer's instructions state that the KwikPen should be primed before each injection.
Priming helps remove air from the cartridge and helps ensure that the pen is ready to deliver the intended dose.
Patients should always follow the instructions supplied with their specific medication rather than relying on online demonstrations or social media videos.
What happens after the fourth Mounjaro injection?
After you have administered the fourth weekly dose, the KwikPen should be disposed of according to the manufacturer's instructions.
Do not attempt to obtain another dose from the remaining liquid.
The manufacturer's UK guidance states that the KwikPen should be disposed of after administration of four doses or 30 days after first use, according to the applicable instructions.
Your pharmacist can advise you about appropriate disposal arrangements in your area.
Can the new Mounjaro pen affect weight-loss results?
There is no reason to expect the pen design itself to change the effectiveness of your prescribed Mounjaro treatment.
The modification concerns the device mechanism rather than changing the active ingredient or the intended dose.
Mounjaro contains tirzepatide and works on both GIP and GLP-1 receptors involved in appetite regulation and metabolic processes.
However, individual weight-loss results vary.
Your response can be influenced by factors including your starting weight, prescribed dose, treatment duration, diet, physical activity, medical history and individual response.
If you want to understand more about weight-loss injections, our guide to weight loss injections in the UK explains how treatments such as Mounjaro and Wegovy work and what to consider before treatment.
What should I do if my Mounjaro pen looks different?
If your new pen looks different from a previous Mounjaro KwikPen, don't panic.
The modified and initial versions may look different but are designed to work in the same way.
Before using the pen:
- Check the name and strength of the medicine.
- Check the expiry date.
- Check that the pen is not damaged.
- Check that the medicine looks as described in the Instructions for Use.
- Read the instructions supplied with your pen.
- Use a new compatible needle for each injection.
- Prime the pen before each injection.
- Never share your pen with another person.
If something does not look right or you are unsure whether the pen is suitable for use, contact your pharmacist or prescribing clinician.
What if the Mounjaro pen is difficult to use?
Occasionally, patients may find that the dose knob becomes difficult to push.
This does not necessarily mean that the pen itself is defective.
The manufacturer advises that a blocked needle or contamination of the pen can contribute to difficulty pressing the dose knob. Using a new needle and following the correct priming procedure may help.
If the pen has been exposed to substances such as dust, food or liquid, or appears damaged, it should not be used.
If you are unable to administer your prescribed dose correctly, contact your prescribing clinician or pharmacist rather than trying to force the device or taking an additional dose.
What about Mounjaro side effects?
The change to the KwikPen does not mean that the medicine's side-effect profile has changed.
As with any prescription medicine, Mounjaro can cause side effects.
Common side effects may include:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Abdominal discomfort
- Reduced appetite
Side effects can be more noticeable when treatment is started or when the dose is increased.
If you are experiencing side effects while taking Mounjaro, speak to your prescriber or pharmacist for individual advice.
You can also explore the weight loss treatments available through SynovaMed to learn more about the different prescription options available.
Is Mounjaro still available through SynovaMed?
Yes.
SynovaMed provides Mounjaro weight loss treatment following an appropriate clinical consultation and prescriber assessment.
Mounjaro is a prescription medicine, so treatment is not automatically suitable for everyone.
Our clinicians consider factors such as your BMI, medical history, existing health conditions and current medicines when assessing whether treatment may be appropriate.
SynovaMed also provides a range of weight loss treatments, including prescription injections and oral options.
What should I remember about the 2026 Mounjaro KwikPen change?
The key points are:
The Mounjaro KwikPen has been updated.
The modified version may look slightly different from the original.
The medicine has not been changed because of the pen update.
The pen continues to deliver your prescribed tirzepatide dose.
The injection process remains essentially the same.
Continue to prime and use the pen according to the manufacturer's instructions.
Each pen provides four weekly doses.
Do not treat leftover liquid after the fourth dose as an additional injection.
Do not attempt to extract a "fifth dose".
The remaining liquid is not intended to be used as another weekly dose.
Both versions may be encountered during the transition.
A different-looking pen does not automatically mean that something is wrong.
If you are unsure, ask your pharmacist or prescriber.
It is always better to check before administering a dose if you have concerns about your device.
Frequently Asked Questions
Has the Mounjaro KwikPen changed in 2026?
Yes. A modified version of the Mounjaro KwikPen has been introduced. The internal mechanism and plunger design have been adjusted, while the two versions are designed to work in the same way.
Does the new Mounjaro pen work differently?
No. The injection process remains the same. Patients should continue to follow the Instructions for Use supplied with their medication.
How many doses are in a Mounjaro KwikPen?
Each KwikPen is designed to deliver four fixed weekly doses.
Is there a fifth dose in Mounjaro?
No. Although some liquid may remain in the cartridge after four doses, the KwikPen is designed to provide four doses. The remaining liquid should not be treated as an additional dose.
Why is there Mounjaro left in the pen?
The pen contains additional volume to allow it to be primed before injections. Some liquid may therefore remain after the four intended doses have been administered.
Does the new Mounjaro pen contain less medicine?
No. The design change does not mean that your prescribed Mounjaro dose has been reduced.
Do I need to prime the new Mounjaro pen?
Yes. The KwikPen should be primed before each injection according to the manufacturer's instructions.
Can I use the leftover Mounjaro after my fourth dose?
No. Do not attempt to extract or inject the remaining liquid as an additional dose. The pen is designed for four doses.
Why does my new Mounjaro pen look different?
The modified KwikPen has changes to its internal mechanism and plunger design. The original and modified versions may therefore look slightly different while working in the same way.
Should I change my Mounjaro dose because of the new pen?
No. Do not change your dose because of the pen design. Your dose should only be changed following advice from your prescribing clinician.
What should I do if I am unsure about my Mounjaro pen?
Do not guess or alter the way you use it. Check the Instructions for Use supplied with the pen and contact your pharmacist or prescribing clinician if you remain unsure.
Start Your Mounjaro Weight-Loss Treatment With SynovaMed
The 2026 Mounjaro KwikPen update is primarily a device change designed to make the end of the four-dose pen clearer.
For patients, the most important thing to remember is that the updated pen is still designed for four weekly doses and should be used according to the manufacturer's instructions.
If you are considering Mounjaro for weight management, you can check your eligibility for Mounjaro through SynovaMed's online clinical consultation.
Alternatively, explore our weight loss treatments to see the prescription options available.
Medical Disclaimer
This article is intended for general information and does not replace individual medical advice. Mounjaro (tirzepatide) is a prescription medicine and is not suitable for everyone. Treatment, dosage and ongoing use should be determined by an appropriately qualified prescriber following a clinical assessment. Always follow the Patient Information Leaflet and Instructions for Use supplied with your medicine. If you are concerned about your medication, pen or symptoms, speak to your pharmacist or healthcare professional.